Abstract:OBJECTIVE:To investigate the instant effects of continuous positive airway pressure (CPAP) on EEG spectral power changes in obstructive sleep apnea syndrome (OSAS) patients. METHODS:26 OSAS patients were included. The diagnosis was made by polysomnography (PSG). The CPAP pressure was titrated during the first night of therapy. During another night in two weeks after the diagnostic study, the patients accepted the whole night CPAP treatment while PSG was monitored. C(3)/A(2) was analyzed by using fast fourier transform (FFT). Spectral edge frequency (SEF), median power frequency (MPF), alpha index, beta index, delta index and theta; index during CPAP therapy were compared with those parameters before treatment. RESULTS:Sleep architecture was improved significantly during therapy. The ratio of slow wave sleep (SWS) deficiency reduced from 19/26 to 10/26 (P = 0.0250). There were more times of REM sleep (1.81 +/- 0.25) vs (2.65 +/- 0.17) (P = 0.023). A significant increase of total SWS time over total sleep time (TST) (2.9 +/- 1.1)% vs (6.0 +/- 1.2)% (P = 0.043) was observed, as well as total REM sleep time over TST (12.0 +/- 1.7)% vs (21.1 +/- 1.6)% (P = 0.001). Total stage I and stage II time over TST reduced greatly [from (85.1 +/- 2.1)% to (73.0 +/- 1.9)% (P = 0.000)]. So did the number of wake after sleep onset [from (12.2 +/- 1.3) to (9.4 +/- 1.0) (P = 0.033). The total number of stage I, stage II decreased from (46.4 +/- 4.2) to (36.7 +/- 2.4), but the difference was not significant (P = 0.051). Spectral analysis of EEG showed a decrease of mean SEF in total sleep period (TSP) (14.4 +/- 0.4) Hz vs (13.6 +/- 0.3) Hz (P = 0.003), stage I (15.4 +/- 0.4) Hz vs (14.8 +/- 0.5) Hz (P = 0.040), stage II (13.7 +/- 0.3) Hz vs (12.8 +/- 0.3) Hz (P = 0.007) and REM sleep (15.0 +/- 0.5) Hz vs (13.8 +/- 0.6) Hz (P = 0.028), as well as 0.018 and 0.047]. delta index was increased in stage II sleep (P = 0.030) but not in other sleep stages. CPAP had no obvious influence on theta; index (P > 0.05). The median of SEF in TSP (14 vs 13) Hz (P = 0.0056), stage I (16 vs 15) Hz (P = 0.04) and stage II (13 vs 13) Hz (P = 0.002). Changes of MPF were not as significant as that of SEF, but mean MPF was decreased during TSP and stage IV. CPAP significantly reduced mean beta index [from (8.4 +/- 0.5)% to (7.5 +/- 0.5)% (P = 0.012)] in total sleep period as well as in stage I, II, III and IV sleep (P < 0.015). alpha index in TSP, stage III and IV sleep was decreased significantly (P = 0.045, 0.018 and 0.047 respectively). delta index was increased in stage II sleep (P = 0.030) but not in other sleep stages. CPAP had no obvious influence on theta; index (P > 0.05). CONCLUSIONS:CPAP has an acute effect in improving the sleep architecture and EEG power spectrum. The SEF, beta index and alpha index are more sensitive than MPF, delta index and theta; index to CPAP therapy. These changes may be related to the recovery of cerebral function in OSAS patients after CPAP therapy. More studies need to be conducted to investigate how these changes happen and their relation to daytime cerebral function.

Prediction of the level of continuous positive airway pressure in the mangemeut of obstructive sleep apnea syndrome

Useful variables during wake and sleep for prediction of positive airway pressure in obstructive sleep apnea titration

Obstructive sleep apnea syndrome treated by continous positive airway pressure

Value of Pulse Oximetry for Diagnosing Obstructive Sleep Apnea-Hypopnea Syndrome and Evaluation of the Effect of the Continuous Positive Airway Pressure Therapy

Nasal continuous positive airway pressure treat obstructive sleep apnea syndrome

Evaluation of the value of PSG and blood oxygenation monitoring in patients with OSAHS

The Variation of the CPAP Level During the Treatment of Sleep Apnea Hypopnea Syndrome

Survey on the compliance of the continuous positive airway pressure in obstructive sleep apnea hypopnea syndrome

Effects of CPAP treatment on electroencephalographic activity in patients with obstructive sleep apnea syndrome during deep sleep: Preliminary findings of a cross-sectional study

Predictors of Long-Term Adherence to Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea and Cardiovascular Disease in the Save Study

Continuous Positive Airway Pressure Treatment for Functional Cardiac Arrhythmias Combined with Obstructive Sleep Apnea Hypopnea Syndrome

The Effett of Dornir CPAP Home Ventilator on Treatment of Obstructive Sleep Apnea Syndrome

[Electroencephalogram Spectral Power Analysis of Obstructive Sleep Apnea Syndrome Patients Before and During Continuous Positive Airway Pressure Therapy].

Effect on Quality of Life of Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea Syndrome: A Meta-analysis

Analysis of the improvement of quality of life in patients with obstructive sleep apnea hypopnea syndromes associated hypertension with continuous positive airway pressure

Study on 24H-Blood Pressure Variability in Patients of Obstructive Sleep Apnea with Continuous Positive Airway Pressure Therapy

Epworth Sleepiness Score for Patients with Obstructive Sleep Apnea and Hypopnea Syndrome after Long Term CPAP Treatment

Predictors of changes in cerebral perfusion and oxygenation during obstructive sleep apnea

Identifying Longitudinal Patterns of CPAP Treatment in OSA Using Growth Mixture Modeling: Disease Characteristics and Psychological Determinants

Efficacy of intensive treatment by automatic continuous positive airway pressure in elderly patients with obstructive sleep apnea-hypopnea syndrome

Predictors of Continuous Positive Airway Pressure Adherence and Comparison of Clinical Factors and Polysomnography Findings Between Compliant and Non-Compliant Korean Adults With Obstructive Sleep Apnea